Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C155 - Movement Disorders: Huntington's Disease

Thursday 04/07/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Karen S. Marder, MD, MPH, FAAN
Movement Disorders
Participants should understand new evidence explaining variable age at onset in Huntington's and implications for genetic testing, apply a multidisciplinary approach to treatment for motor, cognitive, and psychiatric impairments across the lifespan, and critically evaluate pharmacological and nonpharmacological current and future clinical trials in HD.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction What's New in Huntington's Disease
Karen S. Marder, MD, MPH, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Karen S. Marder, MD, MPH, FAAN
07:05 AM - 07:35 AM PDT Speaker Genetic Modifiers of Age at Onset in HD: A Paradigm Shift
Suman Jayadev, MD
07:35 AM - 07:40 AM PDT Q&A Genetic Modifiers of Age at Onset: A Paradigm Shift
Suman Jayadev, MD
07:40 AM - 08:10 AM PDT Speaker Multidisciplinary Approach to HD Care Across the Lifespan
Lauren Seeberger, MD, FAAN
08:10 AM - 08:15 AM PDT Q&A Multidisciplinary Approach to HD Care Across the Lifespan
Lauren Seeberger, MD, FAAN
08:15 AM - 08:45 AM PDT Speaker Update on Clinical Trials in Huntington's Disease
Andrew S. Feigin, MD
08:45 AM - 08:50 AM PDT Q&A Update on Clinical Trials in Huntington's Disease
Andrew S. Feigin, MD
08:50 AM - 09:00 AM PDT Q&A Questions and Answers
Karen S. Marder, MD, MPH, FAAN, Lauren Seeberger, MD, FAAN, Andrew S. Feigin, MD
Faculty Disclosures
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Lauren Seeberger, MD, FAAN Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Andrew S. Feigin, MD Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Suman Jayadev, MD Dr. Jayadev has nothing to disclose.